Search

Author/Creator Vicente, D

1. 1665PDPreliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study. (23rd October 2018)

Authors:
Bondarenko, I; Juan-Vidal, O; Pajkos, G; Kryzhanivska, A; Pápai Székely, Z; Vicente, D; Vynnychenko, I O; Jones, S; Wang, Y; Jiang, H; Reinmuth, N
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 322PThree-year overall survival update from the PACIFIC trial. (24th November 2019)

Authors:
Wu, Y-L; Gray, J E; Villegas, A; Daniel, D B; Vicente, D; Murakami, S; Hui, R; Kurata, T; Chiappori, A; Lee, K H; Cho, B C; Planchard, D; Paz-Ares, L; Faivre-Finn, C; Vansteenkiste, J F; Spigel, D R; Taboada, M; Dennis, P A; Özgüroğlu, M; Antonia, S J
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 473PASTRIS global real world study of osimertinib in patients (pts) with EGFR T790M non-small cell lung cancer (NSCLC): Subpopulation analyses. (25th November 2018)

Authors:
Provencio, M; Cheema, P K; Vansteenkiste, J F; Cho, B C; Zhou, C; Yu, J; Martin, C; Park, K; He, Y; Hu, Y; Vicente, D; Miranda, M; Rigas, J; de Marinis, F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331. (17th December 2018)

Authors:
Reck, M; Vicente, D; Ciuleanu, T; Gettinger, S; Peters, S; Horn, L; Audigier-Valette, C; Pardo, N; Juan-Vidal, O; Cheng, Y; Zhang, H; Shi, M; Wolf, J; Antonia, S J; Nakagawa, K; Selvaggi, G; Baudelet, C; Chang, H; Spigel, D R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. LBA62Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407. (23rd October 2018)

Authors:
Mazières, J; Kowalski, D; Luft, A; Vicente, D; Tafreshi, A; Gümüş, M; Laktionov, K; Hermes, B; Cicin, I; Rodríguez-Cid, J; Wilson, J; Kato, T; Ramlau, R; Novello, S; Reddy, S; Piperdi, B; Li, X; Burke, T; Paz-Ares, L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018)

Authors:
Rizvi, N A; Chul Cho, B; Reinmuth, N; Lee, K H; Ahn, M-J; Luft, A; van den Heuvel, M; Cobo, M; Smolin, A; Vicente, D; Moiseyenko, V; Antonia, S J; Le Moulec, S; Robinet, G; Natale, R; Nakagawa, K; Zhao, L; Stockman, P K; Chand, V; Peters, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P-293Comorbidities (CM) and potential impact in outcomes of advanced colorectal cancer patients (ACC) in Argentina: EVIREPRO real life program - Trial in progress. (20th June 2018)

Authors:
Schmilovich, A; Ramello, F; Malicki, M; Berra, N Colombo; Rojo, S; Davila, G; Binner, V; Barrionuevo, H; Capria, J; Poggio, M; Arca, R; Tabares, D; Vicente, D; Santillan, D; Burre, J; Vazquez, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗